Isfahan University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial
Nadia Najafizade
Nadia Najafizade

Assistant Professor of Radiotherapy

Department of Radiooncology, School of Medicine

Cancer Prevention Research Center

Seyyed Al-Shohada Hospital

Isfahan University of Medical Sciences

All Documents
16. Sensitivity Analysis of a 6 Mev Photon Beam Monte Carlo Model, Journal of Medical Signals and Sensors (2023)